CARRA October 2020 Newsleter - Issue 2


Recent Research Spotlight

“Adverse Childhood Experiences Are Associated with Childhood-Onset Arthritis in a National Sample of US Youth: An Analysis of the 2016 National Survey of Children's Health” was published in the Journal of Pediatrics this summer. The article, authored by CARRA members Tamar Rubenstein, MD, MS, Kaveh Ardalan, MD, MS and Danielle Bullock, MD, MPH, with their colleagues, Wenzhu Mowrey, PhD, Nicole M. Brown, MD, MPH, MHS, Laurie Bauman, PhD, and Ruth Stein, MD, examines the relationship between Adverse Childhood Experiences (ACEs) and juvenile arthritis. In this study, the authors found that children with a higher number of ACEs were more likely to have arthritis, when compared to healthy children or children with other acquired chronic physical disease (OCPD).

While we all miss our in-person meetings, the publication of this study shows how valuable the collaboration between CARRA members can be. The idea for this study originated at an Early Investigator CARRA meeting, blossomed into a collaboration between the authors and ultimately led them to purse a CARRA grant to fund their research. Let’s keep collaborating virtually and utilizing the CARRA network to conduct impactful research! Congratulations to the authors!

Click here to read the full article.

Application Deadline Approaching for Two NEW 2020 Grants

CARRA-Arthritis Foundation Implementation Science Design Grant

Letter of Intent Due: November 1

Application Due: December 1

This funding opportunity is intended to support investigator teams at multiple (2-3) sites to conduct Implementation Science Design projects

Funding Amount: $25,000

  • Letter of Intent Due: November 1
  • Application Due: December 1

             Funding/Project Period: March 1, 2021-August 31, 2021

Click here to learn more.

CARRA-PReS Collaborative Research Award

Applications Due: December 1

The purpose of this funding mechanism is to support collaborative research activities between CARRA and PReS early career investigators.

Funding Amount: €25,000 EUR ($29,766 USD)
Application Deadline: December 1, 2020
Funding/Project Period: March 1, 2021--February 28, 2022

Click here to learn more.

News and Notes

CARRA Registry Stats (as of 10/19/20)

+ 505 biosamples collected!

CARRA Publication Policy: Important Information

It is crucial we continue to share the results of research! In order to help CARRA continue to spread the word about the amazing work our members are doing, we need your help!

All CARRA-related publications are subject to CARRA’s Authorship, Publication and Presentation Guidelines and must be reviewed by the Publications Committee ([email protected]) prior to submitting for publication.

This includes abstracts submitted for presentation at the upcoming ACR meeting. If you have an abstract accepted for presentation that is CARRA-related, and has not been reviewed by the Publications Committee, please submit your abstract for review as soon as possible via the link below.

CARRA-related publications include:

  • Analysis of data and biospecimens collected via CARRA-sponsored or CARRA-funded protocols, including the CARRA Registry and sub-studies
  • Analysis of data and biospecimens shared via the CARRA Data and Sample Share Committee application process
  • CARRA-Arthritis Foundation Grants
  • Other studies authorized to be managed by the CARRA Publications Committee after completion of the primary study
  • Analysis of data obtained via surveys of the CARRA membership (including subsets)
  • CARRA Consensus Treatment Plans (CTPs)
  • Utilization of CARRA infrastructure or intellectual property, including but not limited to mailing lists, conference call time, annual meeting space, funding, or other support provided by or in collaboration with CARRA

Please remember to submit within the policy’s timelines for review:

  • Abstracts: 7 Days
  • Meeting Proceeding: 7 Days
  • Paper/Manuscript: 3 Weeks
  • Poster: 7 Days
  • Press Release: 7 Days
  • Slides: 7 Days

Click here to review the full policy, which includes separate procedures for Consensus Treatment Plan primary manuscripts. If you published on a CARRA-related project that was not previously approved by the Publications Committee or is not our website, please send the complete article or abstract to [email protected].

If you have any questions, please email [email protected].

Important Dates and Deadlines